Related Experiment Video
Updated: Jul 22, 2026
04:19
A Computer-Based Platform for Aiding Clinicians in Eating Disorder Analysis and Diagnosis
Published on: May 10, 2022
Development and validation of the Diabetes Care Profile.
J T Fitzgerald1, W K Davis, C M Connell
1University of Michigan, USA.
Evaluation & the Health Professions
|May 7, 1996
Summary
The Diabetes Care Profile (DCP) is a reliable and valid tool for assessing psychosocial factors in diabetes management. This instrument helps understand social and psychological aspects influencing diabetes treatment outcomes.
Area of Science:
- Psychology
- Endocrinology
- Medical Instruments
Background:
- Psychosocial factors significantly impact diabetes management and treatment adherence.
- Existing instruments may not fully capture the complex interplay of social and psychological elements in diabetes care.
Purpose of the Study:
- To evaluate the reliability and validity of the Diabetes Care Profile (DCP).
- To confirm the DCP's utility in assessing psychosocial factors pertinent to diabetes and its treatment.
Main Methods:
- Two studies were conducted with separate populations and methodologies.
- Study 1: Administered DCP and collected physiologic measures from 440 community-based individuals with diabetes.
- Study 2: Administered DCP and validated scales to 352 individuals with diabetes at a university medical center.
Main Results:
- Cronbach's alphas for DCP scales ranged from .60 to .95 (Study 1) and .66 to .94 (Study 2), indicating high reliability.
- Glycohemoglobin levels correlated with three DCP scales in Study 1.
- Several DCP scales effectively differentiated patients across varying disease severity levels.
Conclusions:
- The Diabetes Care Profile (DCP) demonstrates strong reliability and validity.
- The DCP is a suitable instrument for measuring psychosocial factors in individuals with diabetes.
- Findings support the use of the DCP in clinical and research settings for diabetes care.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...